Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length

American Journal of Psychiatry

Volumn 173, Issue 6, 2016, Pages 617-624

  Verhoeven, Josine E ^a   Van Oppen, Patricia ^a   Révész, Dóra ^a   Wolkowitz, Owen M ^a   Penninx, Brenda W J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CELLULAR PARAMETERS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REMISSION; SEX RATIO; SHORT LEUKOCYTE TELOMERE LENGTH; SOCIAL STATUS; ANXIETY DISORDERS; CASE CONTROL STUDY; DEPRESSIVE DISORDER; GENETICS; LEUKOCYTE; METABOLISM; TELOMERE SHORTENING;

ADULT; ANXIETY DISORDERS; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; LEUKOCYTES; LONGITUDINAL STUDIES; MALE; TELOMERE SHORTENING;

EID: 84973349082     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15070887     Document Type: Article

References (43)

1. Schutte NS, Malouff JM: The association between depression and leukocyte telomere length: a meta-analysis. Depress Anxiety 2015; 32:229-238
2. Penninx BWJH, Milaneschi Y, Lamers F, et al: Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. BMC Med 2013; 11:129
3. Roy-Byrne PP, Davidson KW, Kessler RC, et al: Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry 2008; 30:208-225
4. Dowlati Y, Herrmann N, Swardfager W, et al: A meta-analysis of cytokines in major depression. Biol Psychiatry 2010; 67:446-457
5. Black CN, Bot M, Scheffer PG, et al: Is depression associated with increased oxidative stress? a systematic review and meta-analysis. Psychoneuroendocrinology 2015; 51:164-175
6. Gotlib IH, LeMoult J, Colich NL, et al: Telomere length and cortisol reactivity in children of depressedmothers. Mol Psychiatry 2015; 20: 615-620
7. Blackburn EH: Switching and signaling at the telomere. Cell 2001; 106:661-673
8. Lindqvist D, Epel ES, Mellon SH, et al: Psychiatric disorders and leukocyte telomere length: underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev 2015; 55:333-364
9. Cawthon RM, Smith KR, O'Brien E, et al: Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003; 361:393-395
10. Schaakxs R, Verhoeven JE, Oude Voshaar RC, et al: Leukocyte telomere length and late-life depression. Am J Geriatr Psychiatry 2015; 23:423-432
11. Teyssier JR, Chauvet-Gelinier JC, Ragot S, et al: Up-regulation of leucocytes genes implicated in telomere dysfunction and cellular senescence correlates with depression and anxiety severity scores. PLoS One 2012; 7:e49677
12. Simon NM, Walton ZE, Bui E, et al: Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls. Psychoneuroendocrinology 2015; 58:9-22
13. Hoen PW, de Jonge P, Na BY, et al: Depression and leukocyte telomere length in patients with coronary heart disease: data from the Heart and Soul Study. Psychosom Med 2011; 73:541-547
14. Simon NM, Smoller JW, McNamara KL, et al: Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60:432-435
15. Wikgren M, Maripuu M, Karlsson T, et al: Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 2012; 71:294-300
16. Cai N, Chang S, Li Y, et al: Molecular signatures of major depression. Curr Biol 2015; 25:1146-1156
17. Verhoeven JE, Révész D, Epel ES, et al: Major depressive disorder and accelerated cellularaging: results fromalarge psychiatric cohort study. Mol Psychiatry 2014; 19:895-901
18. Verhoeven JE, Révész D, van Oppen P, et al: Anxiety disorders and accelerated cellular ageing. Br J Psychiatry 2015; 206:371-378
19. Kananen L, Surakka I, Pirkola S, et al: Childhood adversities are associated with shorter telomere length at adultage both in individuals with an anxiety disorder and controls. PLoS One 2010; 5:e10826
20. Shalev I, Moffitt TE, Braithwaite AW, et al: Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumaticstress disorder. Mol Psychiatry 2014; 19:1163-1170
21. Penninx BWJH, Beekman ATF, Smit JH, et al: The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008; 17:121-140
22. Rush AJ, Gullion CM, Basco MR, et al: The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996; 26:477-486
23. Beck AT, Epstein N, Brown G, et al: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988; 56:893-897
24. Lyketsos CG, Nestadt G, Cwi J, et al: The Life-Chart interview: a standardized method to describe the course of psychopathology. Int J Methods Psychiatr Res 1994; 4:143-155
25. Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47
26. Craig CL, Marshall AL, Sjöström M, et al: International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35:1381-1395
27. World Health Organization Collaboration Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) Classification System. Olso, Norway, World Health Organization Collaboration Centre for Drug Statistics Methodology, 2007
28. Twisk JWR: Longitudinal data analysis: a comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol 2004; 19:769-776
29. Epel E: How "reversible" is telomeric aging? Cancer PrevRes (Phila) 2012; 5:1163-1168
30. Verhoeven JE, Révész D, Wolkowitz OM, et al: Cellular aging in depression: permanent imprint or reversible process? an overview of the current evidence, mechanistic pathways, and targets for interventions. BioEssays 2014; 36:968-978
31. Lamers F, van Oppen P, Comijs HC, et al: Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011; 72:341-348
32. Broer L, Codd V, Nyholt DR, et al: Meta-analysis of telomere length in 19,713 subjects reveals high heritability stronger maternal inheritance and a paternal age effect. Eur J Hum Genet 2013; 21:1163-1168
33. Liu Y, Kha H, Ungrin M, et al: Preferential maintenance of critically short telomeres in mammalian cells heterozygous for mTert. Proc Natl Acad Sci USA 2002; 99:3597-3602
34. Lin PY: Shortened leukocyte telomere length in patients with schizophrenia is related to disease status. Schizophr Res 2015; 168:597-598
35. Jergovic M, Tomicevic M, Vidovic A, et al: Telomere shortening and immune activity in war veterans with posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2014; 54:275-283
36. Jaskelioff M, Muller FL, Paik JH, et al: Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 2011; 469:102-106
37. Wei YB, Backlund L, Wegener G, et al: Telomerase dysregulation in the hippocampus of a rat model of depression: normalization by lithium. Int J Neuropsychopharmacol 2015; 18:pyv002
38. Batista LFZ, Pech MF, Zhong FL, et al: Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 2011; 474:399-402
39. Wolkowitz OM, Mellon SH, Epel ES, et al: Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry 2012; 17:164-172
40. Zhou QG, Hu Y, Wu DL, et al: Hippocampal telomerase is involved in the modulation of depressive behaviors. J Neurosci 2011; 31:12258-12269
41. Lin Y, Damjanovic A, Metter EJ, et al: Age-associated telomere attrition of lymphocytes in vivo is co-ordinated with changes in telomerase activity, composition of lymphocyte subsets and health conditions. Clin Sci (Lond) 2015; 128:367-377
42. Daniali L, Benetos A, Susser E, et al: Telomeres shorten at equivalent rates in somatic tissues of adults. Nat Commun 2013; 4:1597
43. Bersani FS, Lindqvist D, Mellon SH, et al: Telomerase activation as a possible mechanism of action for psychopharmacological interventions. Drug Discov Today 2015; 20:1305-1309